# FDA Inspection 845620 - Carter BloodCare - Rosedale - August 23, 2013

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-rosedale/aba3ed0b-e862-42d9-8a7a-5e61bef89382
Source feed: FDA_Inspections

> FDA Inspection 845620 for Carter BloodCare - Rosedale on August 23, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 845620
- Company Name: Carter BloodCare - Rosedale
- Inspection Date: 2013-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1243500 - 2024-06-27](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-rosedale/5ddbf2cb-28f0-4432-a611-1a18e5dd6ca3)
- [FDA Inspection 1077022 - 2019-01-16](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-rosedale/aa052737-64fd-4b38-bb15-1adc6592e280)
- [FDA Inspection 1006650 - 2017-02-08](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-rosedale/96563677-b724-4bab-b2bf-ef63401a0d5a)
- [FDA Inspection 917722 - 2015-02-05](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-rosedale/1015875e-2785-435f-9f6b-1662de6c2830)
- [FDA Inspection 676470 - 2010-08-18](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-rosedale/d650cf73-5dde-472e-9d94-83e19ec2b54a)

Company: https://www.keypedia.com/companies/carter-bloodcare-rosedale/2fd8b808-0c7c-48f2-a71d-5e492b705f60

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d